Blepharoplasty recovery timeline

What happens during recovery

• Complications cluster by week: corneal abrasion and retrobulbar hemorrhage in week 1; lid malposition, exposure and tearing in weeks 1-6; contour change, asymmetry and scarring after that (PMID 20195127).
• Bleeding risk is highest in the first 3 hours after surgery and falls after 24 hours, in a series of 269,433 cosmetic eyelid cases with 149 orbital hemorrhages (0.055%, 1 in 2,000) (PMID 15599241).
• Hemorrhage can still occur after the first 48 hours: 2 case reports describe periocular hemorrhage at 5 and 8 days after uncomplicated upper blepharoplasty, both linked to uncontrolled hypertension (PMID 25797846).
• CosmetAssure data on 6,126 aesthetic eyelid and brow patients: major complications 0.4%, hematoma the most common single complication at 0.2% (PMID 29369102).
• Wound dehiscence after isolated upper blepharoplasty, 2,376 eyelids: 1.4%, at an average of 9 days after surgery (range 0-30 days) (PMID 32852369).
• Tissue removed at surgery with more lymphatic vessels predicts a better early course: in 40 eyelids from 21 ptosis patients, a higher lymphatic vessel area in the excised tissue tracked with lower (better) Vancouver Scar Scale scores at 2 weeks and 1 month; lymphatic vessel density fell with age (PMID 39388768).
• Technique changes the early course: in 386 patients, skin-muscle-fat excision (51 patients) had more complications than skin-only excision (335 patients), 7.8% against 2.4% (p=0.075), and a shorter return to work was reported after skin-only surgery (PMID 39856176).

Recovery care: what the evidence supports

• Cold compresses: a randomized, observer-blinded trial in 38 patients found eyelid cooling did not reduce edema, erythema or hematoma, though it slightly lowered pain on day 1 (PMID 25626811).
• Arnica ointment 10%: a randomized, placebo-controlled trial in 136 patients found no difference from placebo in swelling, bruising, pain or satisfaction (PMID 27348641).
• Oral bromelain: a randomized, triple-blind, placebo-controlled trial of 200 mg every 8 hours for 2 weeks in 46 patients found lower edema scores on days 3, 7 and 11, and lower bruising on day 3 only (PMID 42728656).
• Tranexamic acid (TXA) in the local block: a randomized, double-blind trial in 15 patients found TXA added to lidocaine with epinephrine nearly doubled intraoperative blood loss (4.86 ml against 2.53 ml) with no difference in swelling or bruising by day 7 (PMID 38789809).
• Subcutaneous TXA given separately from the block: a randomized, multicenter, double-masked trial in eyelid surgery (130 patients, 69 having levator advancement) found it reduced bruising at day 0 and at 1 week (PMID 38624153). The two TXA trials used different routes and reached different conclusions on bruising.
• Blood pressure control: a retrospective review of 32 patients having facelift with blepharoplasty, kept below 120 mmHg systolic through the perioperative period, recorded no hematomas; males had higher postoperative blood pressure than females (p=0.05) (PMID 38714536).
• Suture choice and technique affect early bruising and scar score more than the cutting tool: a review found interrupted and subcuticular sutures gave less early ecchymosis and better short-term scar scores than running sutures; scalpel, radiofrequency and CO2 laser incisions produced no difference in final scar; absorbable and nonabsorbable sutures healed alike, though absorbable material avoids a removal visit; silicone-based creams reduced hypertrophic scarring, while cold compresses, compressive dressings and over-the-counter scar products showed minimal benefit (PMID 41193896).
• No study identified in this review reports a specific postoperative day for removing nonabsorbable eyelid sutures; the dehiscence data above (average 9 days) describes when wounds separate, not when sutures are taken out (PMID 32852369).

Results and evidence

• Bleeding risk with blood thinners continued through surgery: in 392 patients, complications were 6.0% on aspirin, warfarin or apixaban (100 patients) against 3.5% not on them (292 patients), p=0.380, with no major bleeding in either group (PMID 42236867).
• A prospective pilot study of 324 oculoplastic patients (252 eyelid procedures) found severe bleeding in 35 patients (10.8%); acetylsalicylic acid use in eyelid surgery, diabetes, renal disease, general anesthesia and longer surgery duration were associated with bleeding, while continuing anticoagulants and preoperative hypertension were not (PMID 40695569).
• A prospective study of 302 oculoplastic patients on antithrombotic therapy who continued their medication found no major intraoperative or perioperative bleeding; one self-resolving postoperative bleed followed upper-lid blepharoplasty in a patient on aspirin and rivaroxaban (PMID 41672423).
• Patient-reported course after upper blepharoplasty with plasma exeresis, a non-scalpel technique, in 16 patients: satisfaction was highest at the day-7 follow-up (p=.038); eyelid edema was the symptom most reported at day 7, itching most reported at day 30 (PMID 33252188). This describes a specific energy-based technique, not standard incisional blepharoplasty.
• A 500-patient study of upper blepharoplasty found overall satisfaction at 3 months was high (86-96% across subgroups); among patients who were dissatisfied, the most common reasons were more visible scarring than expected (50%) and longer-than-expected swelling (27%) (PMID 42625725).

Risks and complications

• Blindness after cosmetic blepharoplasty is rare; a review of about 60 published cases found retrobulbar hemorrhage was a feature of most, with the final injury usually retinal or optic nerve ischemia (PMID 3516289).
• Permanent visual loss after orbital hemorrhage: 12 of 269,433 cosmetic eyelid cases (0.0045%, about 1 in 22,000) (PMID 15599241).
• Male gender was an independent risk factor for wound dehiscence (p=0.0062), alongside fast-absorbing plain gut suture (p=0.0025), in the 2,376-eyelid review above (PMID 32852369).
• Smoking history also raised dehiscence risk in that same series (p<0.0001); age, hypertension, heart disease and diabetes did not (PMID 32852369).

Recovery

• Return to work: the only comparative data identified describe it as shorter after skin-only upper blepharoplasty than after skin-muscle-fat excision, without giving a specific day count for either group (PMID 39856176).
• Screens: no study identified in this review measured screen or computer use specifically after blepharoplasty. General ophthalmology evidence shows video display terminal (VDT) use lowers blink rate and raises incomplete blinking, which worsens dry eye disease (PMID 35122403). In 30 patients with dry eye, spontaneous blink rate fell from 16.8 blinks/min in conversation to 6.6 blinks/min at the start of VDT use and stayed reduced at 5.9 blinks/min after 30 minutes (p<0.001 for both) (PMID 14747951). In 25 healthy volunteers, blink rate during fast-paced and slow-paced computer games fell to about a third and a half of baseline, with more incomplete blinks and worse tear-film stability during the more dynamic task (PMID 21275516). None of these three studies involved blepharoplasty patients or measured recovery after eyelid surgery.
• Contact lenses: no study identified in this review reports when patients may resume wearing their own contact lenses after cosmetic blepharoplasty. The closest published data describe a different clinical situation: in 13 patients (14 eyes) having full-thickness upper eyelid reconstruction, not cosmetic blepharoplasty, a surgeon-placed soft bandage contact lens was worn for a mean 19.5 days (range 7-35 days) with no chemosis, infection or delayed healing (PMID 18771499).
• Exercise: no study identified in this review measured a specific timeline for resuming strenuous activity after blepharoplasty. The bleeding-risk data above, concentrated in the first hours and reported as late as day 8, and the blood-pressure-hematoma link, are the evidence base cited for restricting exertion in the early postoperative period (PMID 15599241), (PMID 25797846), (PMID 38714536).
• Scar maturation: silicone-based creams reduced hypertrophic scarring in the review cited above; cold compresses, compressive dressings and over-the-counter scar products showed minimal benefit and the review states they may be omitted without compromising outcomes (PMID 41193896). Scar scoring (Vancouver Scar Scale) in the lymphatic-anatomy study was tracked at 2 weeks, 1, 3 and 6 months, with the largest between-patient differences seen at 2 weeks and 1 month (PMID 39388768).

Combined procedures

• Combining brow lift with blepharoplasty did not raise the major complication rate in the 6,126-patient CosmetAssure series: 0.4% for combined procedures against 0.4% for blepharoplasty alone and 0.7% for brow lift alone (p=0.65) (PMID 29369102). Technique-specific brow lift recovery is covered in Endoscopic brow lift, Temporal and lateral brow lift and Browpexy and direct brow lift.
• Adding ptosis correction raised revision rates compared with blepharoplasty alone (9.2% against 3.8% in a 278-patient series), a finding covered in full in Blepharoptosis repair.
• Lower-lid and midface recovery data specific to fat repositioning and the tear trough are covered in Lower blepharoplasty and Tear trough and lid-cheek junction surgery.

Current questions

• Cold compresses, arnica and compressive dressings remain widely recommended after blepharoplasty despite randomized trials finding no measurable benefit over placebo or no treatment (PMID 25626811), (PMID 27348641), (PMID 41193896).
• Oral bromelain has one randomized trial (46 patients) showing reduced edema; it has not been replicated (PMID 42728656).
• Tranexamic acid gave opposite bruising results depending on whether it was mixed into the local anesthetic block or injected subcutaneously as a separate step; the two trials used different patient groups and different eyelid procedures, so the discrepancy is not yet resolved (PMID 38789809), (PMID 38624153).
• No identified trial has tested screen use, contact lens timing or exercise resumption specifically after blepharoplasty; current guidance on these points rests on general eye-surface physiology and on the bleeding-risk timeline, not on blepharoplasty-specific outcome data.
• A 500-patient study links social-media-driven expectations to lower satisfaction when recovery (scarring, swelling) runs longer than patients anticipated, suggesting the gap is often in counseling rather than in surgical outcome (PMID 42625725).

Terms

• Ecchymosis: bruising from blood leaking under the skin (PMID 38789809).
• Edema: fluid-related swelling of the eyelid tissue (PMID 42728656).
• Hematoma: a localized collection of blood, the most common major complication after blepharoplasty (PMID 29369102).
• Orbital (retrobulbar) hemorrhage: bleeding behind the eye that can compress the optic nerve (PMID 15599241).
• Wound dehiscence: separation of a healing incision, averaging 9 days after upper blepharoplasty in one series (PMID 32852369).
• Vancouver Scar Scale (VSS): a clinician-rated score of scar pigmentation, vascularity, pliability and height (PMID 39388768).
• Tranexamic acid (TXA): an antifibrinolytic drug studied both in the local anesthetic block and as a separate subcutaneous injection around blepharoplasty (PMID 38624153).
• Bandage (therapeutic) contact lens: a soft lens placed to protect the cornea after eyelid surgery, distinct from a lens worn for vision correction (PMID 18771499).
• Video display terminal (VDT) use: screen use from a computer, tablet or phone, associated with reduced blink rate (PMID 35122403).
• Antithrombotic therapy: anticoagulant or antiplatelet medication, including aspirin, warfarin, apixaban and rivaroxaban (PMID 42236867).

Papers